Navigation Links
Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
Date:11/6/2008

tar.com.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and conjugate chemistry technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules.

For more information on Nektar Therapeutics, please visit http://www.nektar.com.

This press release contains forward-looking statements that reflect the company's current views regarding the status of the company's turnaround, the potential, progress, and clinical plans for the company's proprietary and partnered product pipeline, the value and potential of the company's technology platforms, and the company's financial strength. These forward- looking statements involve risks and uncertainties, including but not limited to: (i) the company's proprietary product candidates and those of its partners are in various stages of clinical development and the risk of failure is high and can occur at any stage prior to regulatory approval; (ii) the timing or success of the commencement or end of clinical trials and commercial launch of partnered products may be delayed or unsuccessful due to slower than anticipated patient enrollment, drug manufacturing challenges, changing standards of care, clinical trial design, clinical outcomes, or delay or failure in obtaining regulatory approval in one or more important markets; (iii) clinical trials are long, expensive and uncertain processes and the risk of failure of any product that is in clinical development and prior to regulatory approval remains high and can occur at any stage due to efficacy, safety or other factors; , and (iv) th
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Announces Second Quarter 2008 Results
3. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
4. Nektar Therapeutics Announces First Quarter 2008 Results
5. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
6. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
7. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
10. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
11. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer and retailer, has ... . The company has rich experience in making fashionable ... stock and ready to ship: celebrity bodycon dresses, mini ... and so forth. All of them are available in ... proud to announce the new collection of celebrity bodycon ...
(Date:8/27/2014)... August 27, 2014 Taking its popular obstacle ... Steele Creek YMCA will host its largest crowd at ... Saturday, September 13 at YMCA Camp Thunderbird . ... divisions: adult, youth and teams. Within each division, runners ... their physical limit - for a worthy cause. All ...
(Date:8/27/2014)... 2014 Today, Zane Benefits, the #1 ... tips for administering a premium reimbursement plan. , ... effect, compliance is top of mind for employers, health ... health insurance and premium reimbursement, there are important compliance ... 35 minute webinar, Zane Benefits President, Rick Lindquist, will ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s running apparel ... Kathrine Switzer, most noted for her brave running of the ... of women’s running clothes that unites the history of women’s ... Movement. , “It is such an honor to ... “Kathrine is the original Skirt – she stood strong, pushing ...
(Date:8/27/2014)... the use of hormone therapy has spawned a prevalent ... silence with hot flashes, according to a study by ... , In the study published in the Aug. 27 ... team found that moderate to severe hot flashes ... in most women. Women with VMS experience more than ...
Breaking Medicine News(10 mins):Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:The high cost of hot flashes: Millions in lost wages preventable 2
... Upgrades new facility from film to IDC 1600 ... - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the ... radiography (DR), today announced that HealthPartners Medical Group,of ... X-Series DR system.,HealthPartners is a multi-specialty physician group ...
... a range of $395 Million to $405 Million; ... ... up 57.4% over first quarter 2007 - Gross profit of $23.9 million, ... up 135.4% over first quarter 2007, WARSAW, Ind., June 24 Symmetry Medical ...
... Exposure Increased 38% From 2001 - 2007, ... advertising practices by alcohol companies from 2001-2007,finds an ... relatively,few industry- sponsored "responsibility" ads. The new study, ... Youth (CAMY) at Georgetown,University, evaluated advertising trends and ...
... Research,Inc. (ADR), one of the world,s leading scientific institutes ... to announce that it,has achieved legal status as a ... fully-operational for a while now," says,Dr. Catlin, a founder ... all official and we,re thrilled, because others can now ...
... China, TUSTIN, Calif., June 24 AMDL, ... specialty pharmaceuticals,announced today its subsidiary Jade Pharmaceutical, Inc. ... two new formulations of its,popular Goodnak(R) anti-aging skin ... injectable formulation, JPI anticipates offering Goodnak in,capsules and ...
... ultrasound exam of the heel may be able to predict ... to osteoporosis, according to a new multicenter study being published ... Along with certain risk factors, including age or recent fall, ... select women who need further bone density testing, such as ...
Cached Medicine News:Health News:HealthPartners Medical Group in Michigan City purchases IDC digital radiography system 2Health News:HealthPartners Medical Group in Michigan City purchases IDC digital radiography system 3Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 2Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 3Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 4Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 5Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 6Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 7Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 8Health News:Alcohol Advertisements Seen by Youth on TV on the Rise, According to a New Report by the Center on Alcohol Marketing and Youth 2Health News:Alcohol Advertisements Seen by Youth on TV on the Rise, According to a New Report by the Center on Alcohol Marketing and Youth 3Health News:Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status 2Health News:AMDL's Goodnak(R) Anti-Aging Skin Care Line Soon Available in Capsule & Lotion Form 2Health News:Simple ultrasound exam may predict osteoporosis risk 2
(Date:8/27/2014)... LONDON , Aug. 27, 2014 /PRNewswire/ ... research report: Collaborative R&D Terms ... https://www.reportbuyer.com/product/2276220/Collaborative-RD-Terms--Agreements-in-Pharma-Biotech-and-Diagnostics.html The ... Biotech and Diagnostics report provides comprehensive understanding ... deals and agreements entered into by the ...
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire-iReach/ -- In ... to bridge the gap between the electronic medical ... embedded links, readers can experience, first-hand, how seamless ... record. Photo - http://photos.prnewswire.com/prnh/20140827/140443 ... central access to imaging from within the patient ...
(Date:8/27/2014)... 27, 2014 About 8 million Americans have ... buildup of fatty plaque in the arteries, according to ... population and in incidences of diabetes and obesity, the ... Lower Extremity Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 ... and interested residents and fellows will be able to ...
Breaking Medicine Technology:Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9DICOM Grid Launches Interactive Guide to Demonstrate Image-Enabling the EMR 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3
... Essence Orthopaedics, Inc., a medical device company focused on ... has introduced their novel, surgeon-designed PONTiS™ Knotless Endotendonous Repair ... Society for Surgery of the Hand (ASSH). ... upper and lower extremity markets, Core Essence Orthopaedics developed ...
... Optimer Pharmaceuticals (NASDAQ: OPTR ) today ... DIFICID™ (fidaxomicin) tablets will be presented at the 2011 ... place September 17-20 in Chicago. DIFICID was approved by ... of 2011 for the treatment of Clostridium difficile ...
Cached Medicine Technology:Core Essence Orthopaedics Unveiled New Flexor Tendon Repair System at ASSH 2011 2Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 2Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 3Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 4Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 5
... Pulse Oximeter monitors SpO2, pulse ... is designed to provide fast, ... The device rejects spontaneous motion ... operator of excess artifacts and ...
... Radical can operate in two additional ... be removed, creating a fully featured handheld ... also be used to upgrade existing equipment ... additinal hardware or software upgrades to improve ...
Halogen-free immersion oil based on ester oil....
Immersion Oil, 150 cs...
Medicine Products: